Jpmorgan Chase & CO Tonix Pharmaceuticals Holding Corp. Transaction History

Jpmorgan Chase & CO

  • $1.14 Trillion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 11, 2023
BUY
$0.46 - $1.3 $111,954 - $316,394
243,380 Added 490.13%
293,036 $172,000
Q4 2022

Feb 13, 2023
BUY
$0.29 - $0.57 $13,752 - $27,031
47,423 Added 2123.73%
49,656 $19,000
Q3 2022

Nov 14, 2022
BUY
$0.53 - $1.9 $1,113 - $3,991
2,101 Added 1591.67%
2,233 $1,000
Q2 2022

Aug 11, 2022
BUY
$1.58 - $7.36 $208 - $971
132 New
132 $0

About Tonix Pharmaceuticals Holding Corp.

TNXP Quotes by TradingView
  • Ticker TNXP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,752,700
  • Market Cap $7.25M
  • Description
  • Tonix Pharmaceuticals Holding Corp., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and licensing therapeutics and diagnostics to treat and prevent human disease and alleviate suffering. Its portfolio includes immunology, rare disease, infectious disease, and central nervous system (CNS) product candid...
More about TNXP
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email